Characterization of Ebola virus entry by using pseudotyped viruses: Identification of receptor-deficient cell lines

Journal of Virology

Volumn 72, Issue 4, 1998, Pages 3155-3160

  Wool Lewis, Rouven J ^a   Bates, Paul ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; CELL LINE; EBOLA VIRUS; HUMAN; HUMAN CELL; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; VIRUS HEMORRHAGIC FEVER; VIRUS PATHOGENESIS; VIRUS REPLICATION;

EID: 0031954296     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.4.3155-3160.1998     Document Type: Article

References (33)

1. Anonymous. 1978. Ebola haemorrhagic fever in Zaire, 1976. Bull. W. H. O. 56:271-293.
2. Bowen, E. T., G. S. Platt, D. I. Simpson, L. B. McArdell, and R. T. Raymond. 1978. Ebola haemorrhagic fever: experimental infection of monkeys. Trans. R. Soc. Trop. Med. Hyg. 72:188-191.
3. Burns, J. C., T. Friedmann, W. Driever, M. Burrascano, and J. K. Yee. 1993. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. USA 90:8033-8037.
4. Carr, C. M., and P. S. Kim. 1993. A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell. 73:823-832.
5. Cocchi, F., A. L. DeVico, A. Garzíno-Demo, S. K. Arya, R. C. Gallo, and P. Lusso. 1995. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270: 1811-1815.
6. Dong, J., M. G. Roth, and E. Hunter. 1992. A chimeric avian retrovirus containing the influenza virus hemagglutinin gene has an expanded host range. J. Virol. 66:7374-7382.
7. Elliott, L. H., M. P. Kiley, and J. B. McCormick. 1985. Descriptive analysis of Ebola virus proteins. Virology 147:169-176.
8. Feldmann, H., C. Will, M. Schikore, W. Slenczka, and H. D. Klenk. 1991. Glycosylation and oligomerization of the spike protein of Marburg virus. Virology 182:353-356.
9. Fisher-Hoch, S. P., G. I. Perez-Oronoz, E. L. Jackson, L. M. Hermann, and B. G. Brown. 1992. Filovirus clearance in non-human primates. Lancet 340: 451-453.
10. Fouchier, R. A. M., B. E. Meyer, J. H. M. Simon, U. Fischer, and M. H. Malim. 1997. HIV-1 infection of non-dividing cells: evidence that the aminoterminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import. EMBO J. 16:4531-4539.
11. Frenia, M. L., S. M. Lafin, and J. A. Barone. 1992. Features and treatment of rabies. Clin. Pharm. 11:37-47.
12. Gallaher, W. R. 1996. Similar structural models of the transmembrane proteins of Ebola and avian sarcoma viruses. Cell 85:477-478.
13. Gilbert, J. M., P. Bates, H. E. Varmus, and J. M. White. 1994. The receptor for the subgroup A avian leukosis-sarcoma viruses binds to subgroup A but not to subgroup C envelope glycoprotein. J. Virol. 68:5623-5628.
14. Gilbert, J. M., D. Mason, and J. M. White. 1990. Fusion of Rous sarcoma virus with host cells does not require exposure to low pH. J. Virol. 64: 5106-5113.
15. Johnson, K. M., J. V. Lange, P. A. Webb, and F. A. Murphy. 1977. Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire. Lancet i:569-571.
16. Kiley, M. P., E. T. Bowen, G. A. Eddy, M. Isaacson, K. M. Johnson, J. B. McCormick, F. A. Murphy, S. R. Pattyn, D. Peters, O. W. Prozesky, R. L. Regnery, D. I. Simpson, W. Slenczka, P. Sureau, G. van der Groen, P. A. Webb, and H. Wulff. 1982. Filoviridae: a taxonomic home for Marburg and Ebola viruses? Intervirology 18:24-32.
17. Krugman, S., J. P. Giles, and J. Hammond. 1971. Viral hepatitis, type B (MS-2 strain) prevention with specific hepatitis B immune serum globulin. JAMA 218:1665-1670.
18. Landau, N. R., K. A. Page, and D. R. Littman. 1991. Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range. J. Virol. 65:162-169.
19. Marsh, M., and A. Helenius. 1989. Virus entry into animal cells. Adv. Virus Res. 36:107-151.
20. Miller, D. K., and J. Lenard. 1980. Inhibition of vesicular stomatitis virus infection by spike glycoprotein. Evidence for an intracellular, G protein-requiring step. J. Cell Biol. 84:430-437.
21. Ohkuma, S., and B. Poole. 1978. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc. Natl. Acad. Sci. USA 75:3327-3331.
22. Peters, C. J., P. B. Jahrling, T. G. Ksiazek, E. D. Johnson, and H. W. Lupton. 1992. Filovirus contamination of cell cultures. Dev. Biol. Stand. 76:267-274.
23. Rong, L., and P. Bates, 1995. Analysis of the subgroup A avian sarcoma and leukosis virus receptor: the 40-residue, cysteine-rich, low-density lipoprotein receptor repeat motif of Tva is sufficient to mediate viral entry. J. Virol. 69: 4847-4853.
24. Rong, L., A. Edinger, and P. Bates. 1997. Role of basic residues in the subgroup-determining region of the subgroup A avian sarcoma and leukosis virus envelope in receptor binding and infection. J. Virol. 71:3458-3465.
25. Sanchez, A. Personal communication.
26. Sancnez, A., S. G. Trappier, B. W. Mahy, C. J. Peters, and S. T. Nichol. 1996. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc. Natl. Acad. Sci. USA 93:3602-3607.
27. Soneoka, Y., P. M. Cannon, E. E. Ramsdale, J. C. Griffiths, G. Romano, S. M. Kingsman, and A. J. Kingsman. 1995. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23:628-633.
28. Suomalainen, M., and H. Garoff. 1994. Incorporation of homologous and heterologous proteins into the envelope of Moloney murine leukemia virus. J. Virol. 68:4879-4889.
29. Sutton, R. E., and D. R. Littman. 1996. Broad host range of human T-cell leukemia virus type 1 demonstrated with an improved pseudotyping system. J. Virol. 70:7322-7326.
30. Swanepoel, R., P. A. Leman, F. J. Burt, N. A. Zachariades, L. E. Braack, T. G. Ksiazek, P. E. Rollin, S. R. Zaki, and C. J. Peters. 1996. Experimental inoculation of plants and animals with Ebola virus. Emerg. Infect. Dis. 2: 321-325.
31. van der Groen, G., P. Webb, K. Johnson, J. Lange, L. Linsday, and L. Elliott. 1978. Growth of Lassa and Ebola viruses in different cell lines, p. 255-260. In S. R. Pattyn (ed.), Ebola virus haemorrhagic fever. Elsevier/North-Holland Biomedical Press, Amsterdam, The Netherlands.
32. Volcnkov, V. E., S. Becker, V. A. Volchkova, V. A. Ternovoj, A. N. Kotov, S. V. Netesov, and H. D. Klenk. 1995. GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology 214:421-430.
33. White, J., K. Matlin, and A. Helenius. 1981. Cell fusion by Semliki Forest, influenza, and vesicular stomatitis viruses. J. Cell Biol. 89:674-679.